Advertisement

Supplemental Material

The links to relevant recommendations of the American College of Obstetricians and Gynecologists are provided as the primary source of supplemental information to that provided in Clinical Updates in Women's Health Care monographs when applicable. The links to resources other than those of the American College of Obstetricians and Gynecologists are provided for information purposes only, and referral to these resources does not imply the endorsement of the American College of Obstetricians and Gynecologists.

Sexuality and Sexual Disorders (Vol XIII, No 2)

For ACOG guidelines on the use of aromatase inhibitors, refer to Aromatase inhibitors in gynecologic practice. ACOG Committee Opinion No. 738. American College of Obstetricians and Gynecologists. Obstet Gynecol 2018;131:e194-9.

For additional information on sexual health, refer to Sexual health. Committee Opinion No. 706. American College of Obstetricians and Gynecologists. Obstet Gynecol 2017;130:e42-7.

For information on testosterone therapy in female sexual dysfunction refer to: Androgen Therapy: A Reappraisal: An Endocrine Society Clinical Practice Guideline.

For information on sexuality education, refer to Comprehensive sexuality education. Committee Opinion No. 678. American College of Obstetricians and Gynecologists. Obstet Gynecol 2016;128:e227-30.

For a compilation of resources on sex and sexuality prepared by the ACOG Resource Center, refer to http://www.acog.org/About_ACOG/ACOG_Departments
/Resource_Center/WEBTREATS_Sex_and_Sexuality

 




Editor
Russell R. Snyder, MD

Associate Editor
Anne E. Burke, MD

Past Editor
Raul Artal, MD

ISSN 1536-3619
Published 6 times per year